본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

비만처방에서의 안전한 마황사용 지침

이용수 39

영문명
The Safety Guidelines for use of Ma-huang in Obesity Treatment
발행기관
한방비만학회
저자명
송미영(Mi Young Song) 김호준(Ho Jun Kim) 이명종(Myeong Jong Lee)
간행물 정보
『대한한방비만학회지』제6권 2호, 17~27쪽, 전체 11쪽
주제분류
의약학 > 한의학
파일형태
PDF
발행일자
2006.12.31
4,120

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Ma-huang (Ephedra sinica) is frequently prescribed for obesity management in oriental medicine. The main component is ephedrine alkaloids which can have serious adverse side effects such as heart attack, stroke, sudden death. There are no scientific guidelines for Ma-huang usage in the safe treatment of obesity in oriental medicine. We reviewed published studies on its safety to make evidence based guidelines. Methods : We searched electronic databases up to May 2006. We limited evidence to controlled trials for efficacy or safety, case reports for safety, and studies for Ma-huang contents analysis. Results and Conclusions : In clinical trials for weight loss, Ma-huang and ephedrine promote modest short-term weight loss but have no serious adverse effects, have only a few adverse effects associated with increased risk of psychiatric, autonomic, gastrointestinal symptoms and heart palpitations. In case reports, there have been serious adverse effects including stroke, heart attack, and death using typical doses of ephedrine or no associated illness. There are factors related to serious adverse effects, such as overuse, lack of standardization, individual sensitivity, and interactions with other drugs. Studies relating to these factors should be analyzed for safe use of Ma-huang and ephedrine. After analyzing related studies, we suggest guidelines for Ma-huang usage. We propose that the dosage should be within 4.5-7.5g per day for up to 6 months for generally healthy individual. It`s use is contraindicated in individuals with heart disease, thyroid disease, diabetes mellitus, hypertension, psychiatric disorders, glaucoma, urination disorders, enlarged prostate, persons using MAOIs, methyldopa and sympathomimetic agents.

목차

Ⅰ. 서 론
Ⅱ. 본 론
Ⅲ. 고 찰
참고문헌

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

송미영(Mi Young Song),김호준(Ho Jun Kim),이명종(Myeong Jong Lee). (2006).비만처방에서의 안전한 마황사용 지침. 대한한방비만학회지, 6 (2), 17-27

MLA

송미영(Mi Young Song),김호준(Ho Jun Kim),이명종(Myeong Jong Lee). "비만처방에서의 안전한 마황사용 지침." 대한한방비만학회지, 6.2(2006): 17-27

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제